Riboflavin, Vitamin A, Zinc, Vitamin B12 and Selenium: study protocols
4 study groups took Riboflavin together with Vitamin A, Zinc, Vitamin B12 and Selenium. These are the doses the studies gave. They are not a recommendation.
Fewer than 5 study groups in one unit match, too few to draw the chart.
Commonly used together
4 of 4 study groups took Riboflavin, Vitamin A, Zinc, Vitamin B12 and Selenium with something else. Shown: what 3 or more different studies gave.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Iodine | 4 |
| Iron | 4 |
| Vitamin E | 4 |
| Copper | 3 |
| Niacin | 3 |
| Thiamine | 3 |
| Vitamin B6 | 3 |
4 study groups
| Study | |||||||
|---|---|---|---|---|---|---|---|
| Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren 2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified | 1.6 mg | 1 mg | 20 mg | 2 mcg | 40 mcg | 335 days | — |
| Daily supplementation of a multiple micronutrient powder improves folate but not thiamine, riboflavin, or vitamin B(12) status among young Laotian children: a randomized controlled trial 2022 · micronutrient powder group (MNP) · Children aged 6–23 months in rural Lao PDR; no disease-based selection, with high prevalence of undernutrition and micronutrient deficiencies | 500 mcg | 400 mcg | 10 mg | 0.9 mcg | 17 mcg | 36 weeks | 130 |
| Assessment of vitamin A, vitamin B(2), vitamin B(12), vitamin K, folate, and choline status following 4 months of multinutrient supplementation in healthy vegans: a randomised, double-blind, placebo-controlled trial 2025 · INT (intervention group; standard and double omega-3 dosage subgroups) · Healthy adults aged 18 years or older who had followed a vegan diet for at least 1 year; no diagnosed vitamin or mineral deficiency | 1.4 mg | 500 mcg | 6.5 mg | 100 mcg | 55 mcg | 120 days | 35 |
| A novel nutritional supplement to reduce plasma homocysteine in nonpregnant women: A randomised controlled trial in The Gambia 2019 · UNIMMAP tablet · Nonpregnant, non-lactating healthy women aged 18–45 years in West Kiang, The Gambia; women of reproductive age with common micronutrient deficiencies in the population | 1.4 mg | — | 15 mg | 2.6 mcg | 65 mcg | 12 weeks | 105 |